Lb Pharmaceuticals (LBRX) Debt Ratio (2024 - 2026)

Lb Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2026.

• In Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, down 94.25% from the prior year.
• Debt Ratio was 0.0 for Q1 2026 at Lb Pharmaceuticals, down from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.07 in Q4 2024 to a low of 0.0 in Q1 2026.
• Historically, Debt Ratio has averaged 0.02 across 3 years, with a median of 0.0 in 2025.
• Biggest YoY gain for Debt Ratio was 94.25% in 2025; the steepest drop was 94.25% in 2025.
• A 3-year view of Debt Ratio shows it stood at 0.07 in 2024, then tumbled by 94.25% to 0.0 in 2025, then tumbled by 32.31% to 0.0 in 2026.
• The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.